Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPrescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Cardiovascular Drug Reviews, 06/26/09
Riley P et al. – A review summarizes the evidence for and against the prescription of statins to pts with nonalcoholic fatty liver disease, a group typically associated with high cardiovascular risk.
Methods- Review of evidence for/against statin use in nonalcoholic fatty liver disease
- Statins are widely prescribed, with a significant role in reducing cardiovascular risk
- Concern for hepatic safety profile may prevent use for pts with concurrent liver pathology
- Contrary to current opinion, considerable evidence for and little evidence against prescription of statins to this population
- Guidelines advising against statin use in this setting should be reviewed
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin
Journal of Viral Hepatitis, 11/09/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Sponsor
Article Search
Sponsor